
Currently out of the existing stock ratings of Yale Jen, 52 are a BUY (98.11%), 1 are a HOLD (1.89%).
Analyst Yale Jen, currently employed at LAIDLAW, has had 25.68% of price targets met with an average potential upside of 40.81%, reached in 333 days on average.
Yale Jen has documented 109 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VKTX, Viking Therapeutics at 12-Feb-2026.
Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) on 12/8/2020. The price target of $200 was fulfilled within 31 days with a profit of $69 (52.67%), with a performance score of 16.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Aug-2024
$19
$10.64 (127.27%)
$17
1 months 10 days ago
(09-Oct-2026)
0/5 (0%)
$5.26 (38.28%)
Buy Since 28-Jan-2025
$20
$11.64 (139.23%)
$23
1 months 26 days ago
(24-Sep-2026)
0/4 (0%)
$5.88 (41.64%)
Hold Since 12-Nov-2025
$20
$11.64 (139.23%)
$8
1 months 26 days ago
(24-Sep-2026)
7/14 (50%)
$5.88 (41.64%)
142
Buy Since 02-Jul-2026
$27
$13.15 (94.95%)
4 months 17 days ago
(02-Jul-2026)
0/1 (0%)
$19.72 (270.88%)
Hold Since 18-Mar-2026
$22
$13.64 (163.16%)
$23
8 months 1 days ago
(18-Mar-2026)
8/11 (72.73%)
$15.45 (235.88%)
99
What Year was the first public recommendation made by Yale Jen?